ResearcherYonsei UniversityActive in the last 2 years
Jae‐Seok Roe
Matched on ORCID iD 0000-0002-9994-3062; OpenAlex author ID A5041332247. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 5
- Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. Last author DOI 10.1007/s00018-025-05945-w↗
- Engrailed-1 Promotes Pancreatic Cancer Metastasis. First author DOI 10.1002/advs.202308537↗
- A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2023.02.049↗
- EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Last author DOI 10.1093/narcan/zcab023↗
- Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Co-author DOI 10.1016/j.cell.2017.07.007↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hwa-Ryeon Kim · 3 shared papers, 2021–2025 · strength 0.69
- Paper Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. DOI 10.1007/s00018-025-05945-w↗
- Paper A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. DOI 10.1053/j.gastro.2023.02.049↗
- Paper EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. DOI 10.1093/narcan/zcab023↗
- June-Ha Shin · 1 shared paper, 2025 · strength 0.42
- David Arthur Tuveson · 3 shared papers, 2017–2024 · strength 0.36
- Paper Engrailed-1 Promotes Pancreatic Cancer Metastasis. DOI 10.1002/advs.202308537↗
- Paper A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. DOI 10.1053/j.gastro.2023.02.049↗
- Paper Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. DOI 10.1016/j.cell.2017.07.007↗
- Chang‐Il Hwang · 3 shared papers, 2017–2024 · strength 0.33
- Hye-Been Yoo · 2 shared papers, 2021–2023 · strength 0.26
- Christopher R. Vakoc · 2 shared papers, 2017–2024 · strength 0.21
- Jean L. Grem · 2 shared papers, 2017–2024 · strength 0.21
- Michael Anthony Hollingsworth · 2 shared papers, 2017–2024 · strength 0.21
- Paul M. Grandgenett · 2 shared papers, 2017–2024 · strength 0.21
- Youngkyu Park · 2 shared papers, 2017–2024 · strength 0.21
- Hervé Tiriac · 2 shared papers, 2017–2024 · strength 0.21
- Koji Miyabayashi · 2 shared papers, 2017–2023 · strength 0.20
- Esak Lee · 1 shared paper, 2024 · strength 0.16
- Claudia Tonelli · 1 shared paper, 2024 · strength 0.16
- Jihao Xu · 1 shared paper, 2024 · strength 0.16
- Anna M. Kolarzyk · 1 shared paper, 2024 · strength 0.16
- Sabrina Ge · 1 shared paper, 2023 · strength 0.15
- Hee Seung Lee · 1 shared paper, 2023 · strength 0.15
- Faiyaz Notta · 1 shared paper, 2023 · strength 0.15
- Seungmin Bang · 1 shared paper, 2023 · strength 0.15
- Mikala Egeblad · 1 shared paper, 2017 · strength 0.05
- Tim D.D. Somerville · 1 shared paper, 2017 · strength 0.05
- Edward Jae-Hoon Kim · 1 shared paper, 2017 · strength 0.05
- Richard Andrew Burkhart · 1 shared paper, 2017 · strength 0.05
- Jonathan M. Buscaglia · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.